id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2026-0133-0001,DEA,DEA-2026-0133,Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I,Proposed Rule,,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T23:36:31Z,2026-00954,0,0,09000064b916130f
DEA-2025-0918-0002,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I",Proposed Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-23T10:00:13Z,2025-22963,0,0,09000064b90da711
DEA-2025-0885-0001,DEA,DEA-2025-0885,Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I,Proposed Rule,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T20:45:21Z,2025-22763,0,0,09000064b90d3470
DEA-2025-0852-0001,DEA,DEA-2025-0852,Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I,Proposed Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-01-13T04:59:59Z,2025-12-24T10:00:21Z,2025-22495,0,0,09000064b90c30e5
DEA-2025-0555-0001,DEA,DEA-2025-0555,Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I,Proposed Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,2025-11-04T04:59:59Z,2025-11-04T10:00:11Z,2025-19348,0,0,09000064b8ff06ce
DEA-2025-0557-0001,DEA,DEA-2025-0557,Designation of P2P Methyl Glycidic Acid as a List I Chemical,Proposed Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,2025-11-04T04:59:59Z,2025-11-04T10:00:11Z,2025-19384,0,0,09000064b8ff05d4
DEA-2022-0145-0006,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I",Proposed Rule,,2025-07-25T04:00:00Z,2025,7,2025-07-25T04:00:00Z,2025-08-26T03:59:59Z,2025-08-21T09:01:13Z,2025-14022,0,0,09000064b8e9caad
DEA-2023-0098-0002,DEA,DEA-2023-0098,Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I,Proposed Rule,,2025-06-26T04:00:00Z,2025,6,2025-06-26T04:00:00Z,,2025-07-07T20:45:40Z,2025-11462,0,0,09000064b8e2ed48
DEA-2025-0078-0001,DEA,DEA-2025-0078,Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2025-06-10T00:00:00Z,2025,6,2025-06-10T00:00:00Z,2025-07-11T03:59:59Z,2025-07-09T09:00:36Z,2025-10372,0,0,09000064b8ded104
DEA-2025-0081-0001,DEA,DEA-2025-0081,Schedules of Controlled Substances: Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I,Proposed Rule,,2025-06-10T00:00:00Z,2025,6,2025-06-10T00:00:00Z,2025-07-11T03:59:59Z,2025-07-04T09:00:31Z,2025-10503,0,0,09000064b8ded153
DEA-2023-0138-0008,DEA,DEA-2023-0138,Designation of Propionyl Chloride as a List I Chemical,Proposed Rule,,2025-06-03T04:00:00Z,2025,6,2025-06-03T04:00:00Z,2025-07-04T03:59:59Z,2025-07-04T09:00:30Z,2025-09983,0,0,09000064b8dd3fbb
DEA-2025-0075-0001,DEA,DEA-2025-0075,Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I,Proposed Rule,,2025-06-03T04:00:00Z,2025,6,2025-06-03T04:00:00Z,2025-07-04T03:59:59Z,2025-07-04T09:00:30Z,2025-09988,0,0,09000064b8dd403e
DEA-2023-0029-35465,DEA,DEA-2023-0029,Special Registrations for Telemedicine and Limited State Telemedicine Registrations,Proposed Rule,,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,2025-03-19T03:59:59Z,2025-03-20T01:00:13Z,2025-01099,0,0,09000064868e2e65
DEA-2024-0144-0001,DEA,DEA-2024-0144,Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I,Proposed Rule,,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-01-30T04:59:59Z,2025-01-02T02:00:54Z,2024-30359,0,0,0900006486894777
DEA-2024-0148-0002,DEA,DEA-2024-0148,Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,2025-01-30T04:59:59Z,2025-01-21T14:06:33Z,2024-30798,0,0,0900006486894772
DEA-2024-0134-0001,DEA,DEA-2024-0134,Possible Control of Phenethyl Bromide as a List I Chemical,Proposed Rule,,2024-10-28T04:00:00Z,2024,10,2024-10-28T04:00:00Z,2024-11-28T04:59:59Z,2024-11-27T19:58:55Z,2024-24616,0,0,09000064867e8844
DEA-2024-0118-0001,DEA,DEA-2024-0118,Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I,Proposed Rule,,2024-09-17T04:00:00Z,2024,9,2024-09-17T04:00:00Z,,2024-09-17T20:04:16Z,2024-21058,0,0,090000648672f856
DEA-2024-0059-42928,DEA,DEA-2024-0059,Schedules of Controlled Substances: Rescheduling of Marijuana,Proposed Rule,,2024-08-29T04:00:00Z,2024,8,2024-08-29T04:00:00Z,,2024-09-03T22:48:28Z,2024-19370,0,0,09000064866b30d2
DEA-2023-0168-0156,DEA,DEA-2023-0168,"Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I; Stay",Proposed Rule,,2024-06-07T04:00:00Z,2024,6,2024-06-07T04:00:00Z,,2024-06-07T16:05:43Z,2024-12504,0,0,090000648659daf8
DEA-2024-0059-0001,DEA,DEA-2024-0059,Schedules of Controlled Substances: Rescheduling of Marijuana,Proposed Rule,,2024-05-21T04:00:00Z,2024,5,2024-05-21T04:00:00Z,2024-07-23T03:59:59Z,2024-12-21T02:00:50Z,2024-11137,0,0,0900006486575c28
DEA-2021-0031-0007,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I",Proposed Rule,,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,2024-05-14T03:59:59Z,2024-05-03T19:54:22Z,2024-07694,0,0,09000064864cd92b
DEA-2023-0168-0155,DEA,DEA-2023-0168,"Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I",Proposed Rule,,2024-04-09T04:00:00Z,2024,4,2024-04-09T04:00:00Z,,2024-06-07T16:06:39Z,2024-07473,0,0,09000064864c2af7
DEA-2023-0148-0026,DEA,DEA-2023-0148,Controlled Substance Destruction Alternatives to Incineration - Extension of Comment Period,Proposed Rule,,2024-01-03T05:00:00Z,2024,1,2024-01-03T05:00:00Z,2024-04-02T03:59:59Z,2024-04-02T01:04:01Z,2023-28964,0,0,0900006486374cf2
DEA-2023-0168-0001,DEA,DEA-2023-0168,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I",Proposed Rule,,2023-12-13T05:00:00Z,2023,12,2023-12-13T05:00:00Z,2024-01-13T04:59:59Z,2024-01-13T20:44:04Z,2023-27289,0,0,09000064863304b8
DEA-2023-0148-0001,DEA,DEA-2023-0148,Controlled Substance Destruction Alternatives to Incineration,Proposed Rule,,2023-10-31T04:00:00Z,2023,10,2023-10-31T04:00:00Z,2024-04-02T03:59:59Z,2024-04-10T01:00:33Z,2023-23984,0,0,090000648619fc8d
DEA-2023-0147-0001,DEA,DEA-2023-0147,Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I,Proposed Rule,,2023-10-25T04:00:00Z,2023,10,2023-10-25T04:00:00Z,,2023-10-25T21:34:00Z,2023-23379,0,0,0900006486134ef2
DEA-2023-0138-0001,DEA,DEA-2023-0138,Propionyl Chloride,Proposed Rule,,2023-10-12T04:00:00Z,2023,10,2023-10-12T04:00:00Z,2023-11-14T04:59:59Z,2023-11-08T02:00:50Z,2023-22570,0,0,09000064860b9810
DEA-2023-0129-0001,DEA,DEA-2023-0129,Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I,Proposed Rule,,2023-09-22T04:00:00Z,2023,9,2023-09-22T04:00:00Z,2023-11-22T04:59:59Z,2023-11-22T02:03:41Z,2023-20439,0,0,0900006485fe5771
DEA-2023-0059-0001,DEA,DEA-2023-0059,Designation as List I Chemicals: Halides of 4-Anilinopiperidine,Proposed Rule,,2023-04-14T04:00:00Z,2023,4,2023-04-14T04:00:00Z,2023-05-16T03:59:59Z,2023-04-14T12:24:33Z,2023-07454,0,0,0900006485948d50
DEA-2023-0057-0001,DEA,DEA-2023-0057,Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents,Proposed Rule,,2023-04-13T04:00:00Z,2023,4,2023-04-13T04:00:00Z,2023-05-16T03:59:59Z,2023-04-20T01:01:08Z,2023-07578,0,0,0900006485940732
DEA-2023-0058-0001,DEA,DEA-2023-0058,Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2023-04-13T04:00:00Z,2023,4,2023-04-13T04:00:00Z,2023-05-16T03:59:59Z,2023-05-16T01:00:59Z,2023-07576,0,0,0900006485941111
DEA-2023-0049-0001,DEA,DEA-2023-0049,"Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I",Proposed Rule,,2023-04-04T04:00:00Z,2023,4,2023-04-04T04:00:00Z,,2023-04-04T15:48:01Z,2023-06893,0,0,09000064858d7f29
DEA-2023-0029-0001,DEA,DEA-2023-0029,Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation,Proposed Rule,,2023-03-01T05:00:00Z,2023,3,2023-03-01T05:00:00Z,2023-04-01T03:59:59Z,2023-04-25T01:00:34Z,2023-04248,0,0,0900006485732548
DEA-2023-0028-0001,DEA,DEA-2023-0028,Expansion of Induction of Buprenorphine via Telemedicine Encounter,Proposed Rule,,2023-03-01T05:00:00Z,2023,3,2023-03-01T05:00:00Z,2023-04-01T03:59:59Z,2023-04-01T23:39:12Z,2023-04217,0,0,09000064857323db
DEA-2023-0016-0001,DEA,DEA-2023-0016,Controlled Substances Ordering System Modernization,Proposed Rule,,2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,2023-04-04T03:59:59Z,2023-04-05T01:01:13Z,2023-01804,0,0,090000648562c18e
DEA-2022-0145-0001,DEA,DEA-2022-0145,"Schedule of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I",Proposed Rule,,2022-12-23T05:00:00Z,2022,12,2022-12-23T05:00:00Z,,2022-12-23T12:54:22Z,2022-27278,0,0,0900006485550cf4
DEA-2022-0102-0001,DEA,DEA-2022-0102,Designation of 4-Piperidone as a List I Chemical,Proposed Rule,,2022-09-22T04:00:00Z,2022,9,2022-09-22T04:00:00Z,2022-10-25T03:59:59Z,2022-10-20T01:01:07Z,2022-19974,0,0,090000648534f58b
DEA-2022-0026-0101,DEA,DEA-2022-0026,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I; Withdrawal",Proposed Rule,,2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T12:38:14Z,2022-18729,0,0,09000064852853f2
DEA-2022-0001-0591,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing",Proposed Rule,,2022-07-27T04:00:00Z,2022,7,2022-07-27T04:00:00Z,,2022-07-27T12:21:18Z,2022-16102,0,0,09000064851ecfe2
DEA-2022-0068-0001,DEA,DEA-2022-0068,Schedules of Controlled Substances: Removal of Fenfluramine From Control,Proposed Rule,,2022-07-19T04:00:00Z,2022,7,2022-07-19T04:00:00Z,2022-08-19T03:59:59Z,2022-07-28T01:00:56Z,2022-15335,0,0,09000064851d1a59
DEA-2022-0058-0001,DEA,DEA-2022-0058,"Providing Controlled Substances to Ocean Vessels, Aircraft, and Other Entities",Proposed Rule,,2022-07-18T04:00:00Z,2022,7,2022-07-18T04:00:00Z,2022-09-17T03:59:59Z,2022-09-17T01:01:02Z,2022-15265,0,0,09000064851cf62e
DEA-2022-0001-0590,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I",Proposed Rule,,2022-07-06T04:00:00Z,2022,7,2022-07-06T04:00:00Z,,2022-07-07T13:59:19Z,2022-14372,0,0,09000064851b25a1
DEA-2022-0027-0001,DEA,DEA-2022-0027,Schedules of Controlled Substances: Exempted Prescription Products,Proposed Rule,,2022-04-12T04:00:00Z,2022,4,2022-04-12T04:00:00Z,2022-05-13T03:59:59Z,2022-05-13T01:00:46Z,2022-07572,0,0,090000648500fc8e
DEA-2022-0026-0001,DEA,DEA-2022-0026,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I",Proposed Rule,,2022-04-11T04:00:00Z,2022,4,2022-04-11T04:00:00Z,2022-06-11T03:59:59Z,2022-06-12T00:21:41Z,2022-07648,0,0,090000648500addc
DEA-2022-0001-0001,DEA,DEA-2022-0001,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I",Proposed Rule,,2022-01-14T05:00:00Z,2022,1,2022-01-14T05:00:00Z,2022-02-15T04:59:59Z,2022-02-16T02:00:43Z,2022-00713,0,0,0900006484f1fcdd
DEA-2021-0030-0001,DEA,DEA-2021-0030,Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I,Proposed Rule,,2021-12-07T05:00:00Z,2021,12,2021-12-07T05:00:00Z,2022-02-08T04:59:59Z,2021-12-11T02:00:42Z,2021-26293,0,0,0900006484ea7915
DEA-2021-0031-0001,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I",Proposed Rule,,2021-12-07T05:00:00Z,2021,12,2021-12-07T05:00:00Z,,2021-12-08T16:07:57Z,2021-26263,0,0,0900006484ea7b00
DEA-2021-0026-0001,DEA,DEA-2021-0026,Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances between Pharmacies for Initial Filling,Proposed Rule,,2021-11-19T05:00:00Z,2021,11,2021-11-19T05:00:00Z,2022-01-19T04:59:59Z,2022-01-20T02:00:23Z,2021-24981,0,0,0900006484e65ef0
DEA-2021-0027-0001,DEA,DEA-2021-0027,Regulation of Telepharmacy Practice,Proposed Rule,,2021-11-17T05:00:00Z,2021,11,2021-11-17T05:00:00Z,2022-01-19T04:59:59Z,2022-01-20T02:00:23Z,2021-24948,0,0,0900006484e56f76
DEA-2021-0025-0001,DEA,DEA-2021-0025,Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control,Proposed Rule,,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2021-12-07T04:59:59Z,2021-11-24T02:02:38Z,2021-23852,0,0,0900006484e17e7d
DEA-2021-0013-0001,DEA,DEA-2021-0013,Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I,Proposed Rule,,2021-09-02T04:00:00Z,2021,9,2021-09-02T04:00:00Z,2021-10-05T03:59:59Z,2021-10-06T01:00:36Z,2021-18843,0,0,0900006484d43832
DEA-2021-0012-0001,DEA,DEA-2021-0012,Schedules of Controlled Substances: Placement of Mesocarb in Schedule I,Proposed Rule,,2021-08-11T04:00:00Z,2021,8,2021-08-11T04:00:00Z,2021-10-13T03:59:59Z,2021-10-14T01:00:34Z,2021-16489,0,0,0900006484c42141
DEA-2021-0011-0001,DEA,DEA-2021-0011,Schedules of Controlled Substances: Placement of Amineptine in Schedule I,Proposed Rule,,2021-07-22T04:00:00Z,2021,7,2021-07-22T04:00:00Z,2021-09-21T03:59:59Z,2021-08-09T01:00:27Z,2021-15331,0,0,0900006484c078c2
DEA-2019-0004-0006,DEA,DEA-2019-0004,"Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I",Proposed Rule,,2021-07-16T04:00:00Z,2021,7,2021-07-16T04:00:00Z,2021-08-17T03:59:59Z,2021-08-18T13:24:48Z,2021-15114,0,0,0900006484bfbc10
DEA-2021-0009-0001,DEA,DEA-2021-0009,"Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine",Proposed Rule,,2021-03-30T04:00:00Z,2021,3,2021-03-30T04:00:00Z,2021-06-02T03:59:59Z,2021-05-11T16:48:13Z,2021-05346,0,0,0900006484a875c3
DEA-2019-0002-0005,DEA,DEA-2019-0002,"Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I",Proposed Rule,,2021-03-30T04:00:00Z,2021,3,2021-03-30T04:00:00Z,2021-04-30T03:59:59Z,2021-04-01T13:19:22Z,2021-06553,0,0,0900006484a8761d
DEA-2021-0007-0001,DEA,DEA-2021-0007,Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2021-03-18T04:00:00Z,2021,3,2021-03-18T04:00:00Z,2021-04-20T03:59:59Z,2021-04-20T01:00:28Z,2021-05589,0,0,0900006484a6ff9d
DEA-2021-0006-0001,DEA,DEA-2021-0006,Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I,Proposed Rule,,2021-03-03T05:00:00Z,2021,3,2021-03-03T05:00:00Z,2021-04-03T03:59:59Z,2021-04-02T01:00:56Z,2021-04214,0,0,0900006484a5c7c4
DEA-2021-0003-0032,DEA,DEA-2021-0003,Suspicious Orders of Controlled Substances,Proposed Rule,,2021-02-25T05:00:00Z,2021,2,2021-02-25T05:00:00Z,2021-03-30T03:59:59Z,2021-03-30T01:00:21Z,2021-03361,0,0,0900006484a4d934
DEA-2021-0005-0001,DEA,DEA-2021-0005,Amending Regulations To Require Online Submission of Applications for and Renewals of Registration,Proposed Rule,,2021-01-07T05:00:00Z,2021,1,2021-01-07T05:00:00Z,2021-03-09T04:59:59Z,2021-03-09T02:00:26Z,2020-28532,0,0,09000064849e5644
DEA-2021-0001-0001,DEA,DEA-2021-0001,"Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals",Proposed Rule,,2020-12-21T05:00:00Z,2020,12,2020-12-21T05:00:00Z,2021-02-20T04:59:59Z,2021-02-25T13:50:56Z,2020-26813,0,0,09000064849aefe0
DEA-2021-0004-0001,DEA,DEA-2021-0004,Schedules of Controlled Substances: Removal of Samidorphan From Control,Proposed Rule,,2020-12-10T05:00:00Z,2020,12,2020-12-10T05:00:00Z,2021-01-12T04:59:59Z,2021-01-12T02:00:35Z,2020-26812,0,0,090000648499556e
DEA-2020-0035-0001,DEA,DEA-2020-0035,Partial Filling of Prescriptions for Schedule II Controlled Substances,Proposed Rule,,2020-12-04T05:00:00Z,2020,12,2020-12-04T05:00:00Z,2021-02-03T04:59:59Z,2021-02-03T02:00:28Z,2020-26291,0,0,0900006484985b6b
DEA-2020-0038-0001,DEA,DEA-2020-0038,Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I,Proposed Rule,,2020-12-03T05:00:00Z,2020,12,2020-12-03T05:00:00Z,,2020-12-23T16:19:53Z,2020-26301,0,0,090000648498412a
DEA-2021-0003-0001,DEA,DEA-2021-0003,Suspicious Orders of Controlled Substances,Proposed Rule,,2020-11-02T05:00:00Z,2020,11,2020-11-02T05:00:00Z,2021-01-05T04:59:59Z,2021-02-25T16:35:27Z,2020-21302,0,0,0900006484945a99
DEA-2020-0029-0001,DEA,DEA-2020-0029,Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017,Proposed Rule,,2020-10-05T04:00:00Z,2020,10,2020-10-05T04:00:00Z,2020-12-05T04:59:59Z,2020-12-06T02:00:55Z,2020-21675,0,0,09000064848ce421
DEA-2020-0027-0001,DEA,DEA-2020-0027,"Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration",Proposed Rule,,2020-09-30T04:00:00Z,2020,9,2020-09-30T04:00:00Z,2020-12-01T04:59:59Z,2020-12-01T02:02:00Z,2020-19309,0,0,09000064848a25f0
DEA-2020-0025-0001,DEA,DEA-2020-0025,Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I,Proposed Rule,,2020-08-27T04:00:00Z,2020,8,2020-08-27T04:00:00Z,2020-09-29T03:59:59Z,2020-09-28T01:01:08Z,2020-19007,0,0,0900006484823d52
DEA-2020-0022-0001,DEA,DEA-2020-0022,Reporting of Theft or Significant Loss of Controlled Substances,Proposed Rule,,2020-07-29T04:00:00Z,2020,7,2020-07-29T04:00:00Z,2020-09-29T03:59:59Z,2020-09-28T01:01:01Z,2020-15635,0,0,09000064847b3625
DEA-2020-0020-0001,DEA,DEA-2020-0020,"Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I",Proposed Rule,,2020-07-13T04:00:00Z,2020,7,2020-07-13T04:00:00Z,2020-08-13T03:59:59Z,2020-08-13T01:01:57Z,2020-14901,0,0,0900006484745b40
DEA-2020-0017-0001,DEA,DEA-2020-0017,Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I,Proposed Rule,,2020-06-18T04:00:00Z,2020,6,2020-06-18T04:00:00Z,,2020-06-19T13:24:57Z,2020-12304,0,0,09000064846f8a81
DEA-2020-0016-0001,DEA,DEA-2020-0016,Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I,Proposed Rule,,2020-05-15T04:00:00Z,2020,5,2020-05-15T04:00:00Z,2020-06-16T03:59:59Z,2020-05-26T16:52:37Z,2020-09599,0,0,090000648460372c
DEA-2020-0015-0001,DEA,DEA-2020-0015,Schedules of Controlled Substances: Placement of Zipeprol in Schedule I,Proposed Rule,,2020-05-14T04:00:00Z,2020,5,2020-05-14T04:00:00Z,2020-07-14T03:59:59Z,2020-07-14T01:01:18Z,2020-09592,0,0,09000064845f501a
DEA-2020-0009-0001,DEA,DEA-2020-0009,"Schedules of Controlled Substances: Placement of 4,4′-DMAR in Schedule I",Proposed Rule,,2020-04-07T04:00:00Z,2020,4,2020-04-07T04:00:00Z,2020-06-09T03:59:59Z,2020-10-19T14:31:29Z,2020-07095,0,0,090000648448e827
DEA-2020-0008-0001,DEA,DEA-2020-0008,Controls To Enhance the Cultivation of Marihuana for Research in the United States,Proposed Rule,,2020-03-23T04:00:00Z,2020,3,2020-03-23T04:00:00Z,2020-05-23T03:59:59Z,2020-06-05T01:02:20Z,2020-05796,0,0,090000648445f2a9
DEA-2020-0007-0001,DEA,DEA-2020-0007,Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants,Proposed Rule,,2020-03-16T04:00:00Z,2020,3,2020-03-16T04:00:00Z,2020-05-16T03:59:59Z,2020-05-16T01:01:44Z,2020-05159,0,0,0900006484447dc2
DEA-2020-0005-0001,DEA,DEA-2020-0005,Registration Requirements for Narcotic Treatment Programs with Mobile Components,Proposed Rule,,2020-02-26T05:00:00Z,2020,2,2020-02-26T05:00:00Z,2020-04-28T03:59:59Z,2020-04-29T01:00:40Z,2020-03627,0,0,09000064843b4e82
DEA-2020-0002-0001,DEA,DEA-2020-0002,"Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I",Proposed Rule,,2020-01-30T05:00:00Z,2020,1,2020-01-30T05:00:00Z,2020-03-03T04:59:59Z,2020-03-03T02:02:48Z,2020-01681,0,0,090000648430aa75
DEA-2017-0010-0005,DEA,DEA-2017-0010,Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I,Proposed Rule,,2019-10-30T04:00:00Z,2019,10,2019-10-30T04:00:00Z,2019-11-30T04:59:59Z,2019-11-28T02:03:10Z,2019-23626,0,0,0900006484109366
DEA-2019-0013-0001,DEA,DEA-2019-0013,Management of Quotas for Controlled Substances and List I Chemicals,Proposed Rule,,2019-10-23T04:00:00Z,2019,10,2019-10-23T04:00:00Z,2019-12-24T04:59:59Z,2019-12-25T02:02:14Z,2019-21989,0,0,09000064840ec847
DEA-2019-0012-0001,DEA,DEA-2019-0012,Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II,Proposed Rule,,2019-09-17T04:00:00Z,2019,9,2019-09-17T04:00:00Z,2019-11-19T04:59:59Z,2019-11-20T02:02:04Z,2019-19786,0,0,0900006483f86082
DEA-2019-0011-0001,DEA,DEA-2019-0011,"Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals",Proposed Rule,,2019-09-13T04:00:00Z,2019,9,2019-09-13T04:00:00Z,2019-11-13T04:59:59Z,2019-11-13T02:04:07Z,2019-19787,0,0,0900006483f545ad
DEA-2019-0007-0001,DEA,DEA-2019-0007,Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control,Proposed Rule,,2019-08-21T04:00:00Z,2019,8,2019-08-21T04:00:00Z,2019-09-21T03:59:59Z,2021-03-14T09:28:20Z,2019-17630,0,0,0900006483e7ef77
DEA-2019-0004-0001,DEA,DEA-2019-0004,"Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I",Proposed Rule,,2019-05-01T04:00:00Z,2019,5,,,2019-05-16T15:23:10Z,2019-08704,0,0,0900006483c223a6
DEA-2016-0020-0008,DEA,DEA-2016-0020,"Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I",Proposed Rule,,2019-04-08T04:00:00Z,2019,4,2019-04-08T04:00:00Z,2019-05-09T03:59:59Z,2019-05-09T01:01:30Z,2019-06853,0,0,0900006483b716a9
DEA-2019-0001-0001,DEA,DEA-2019-0001,New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances,Proposed Rule,,2019-02-21T05:00:00Z,2019,2,2019-02-21T05:00:00Z,2019-04-23T03:59:59Z,2019-04-23T01:01:00Z,2019-02875,0,0,0900006483a94210
DEA-2019-0002-0001,DEA,DEA-2019-0002,"Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I",Proposed Rule,,2018-12-28T05:00:00Z,2018,12,2018-12-28T05:00:00Z,,2019-04-08T13:18:54Z,2018-28110,0,0,09000064839cbf72
DEA-2018-0011-0001,DEA,DEA-2018-0011,Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I,Proposed Rule,,2018-06-13T04:00:00Z,2018,6,,,2018-09-28T13:47:25Z,2018-12669,0,0,09000064834046ca
DEA-2018-0010-0001,DEA,DEA-2018-0010,"Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA into Schedule I",Proposed Rule,,2018-05-30T04:00:00Z,2018,5,,,2018-05-30T12:36:32Z,2018-11531,0,0,090000648330d3ac
DEA-2018-0009-0001,DEA,DEA-2018-0009,Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I,Proposed Rule,,2018-05-10T04:00:00Z,2018,5,2018-05-10T04:00:00Z,2018-06-12T03:59:59Z,2018-06-13T01:05:58Z,2018-10008,0,0,09000064832540d8
DEA-2018-0005-0001,DEA,DEA-2018-0005,Controlled Substances Quotas,Proposed Rule,,2018-04-19T04:00:00Z,2018,4,2018-04-19T04:00:00Z,2018-05-05T03:59:59Z,2018-05-08T01:01:01Z,2018-08111,0,0,09000064831895a3
DEA-2016-0003-0003,DEA,DEA-2016-0003,Schedules of Controlled Substances: Placement of MAB-CHMINACA into Schedule I,Proposed Rule,,2018-01-30T05:00:00Z,2018,1,2018-01-30T05:00:00Z,2018-03-02T04:59:59Z,2018-03-02T02:02:45Z,2018-01747,0,0,0900006482e7c993
DEA-2018-0001-0001,DEA,DEA-2018-0001,Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I,Proposed Rule,,2017-12-29T05:00:00Z,2017,12,2017-12-29T05:00:00Z,,2018-01-05T13:28:52Z,2017-28114,0,0,0900006482d831c7
DEA-2017-0016-0001,DEA,DEA-2017-0016,Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-related Substances in Schedule I,Proposed Rule,,2017-12-13T05:00:00Z,2017,12,,,2017-12-19T14:27:41Z,2017-26854,0,0,0900006482d01f40
DEA-2017-0013-0001,DEA,DEA-2017-0013,Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl into Schedule I,Proposed Rule,,2017-11-21T05:00:00Z,2017,11,,,2017-11-22T14:39:02Z,2017-25077,0,0,0900006482c98388
DEA-2017-0011-0001,DEA,DEA-2017-0011,"Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I",Proposed Rule,,2017-09-12T04:00:00Z,2017,9,,,2017-09-12T14:11:38Z,2017-19283,0,0,0900006482b28c4e
DEA-2017-0010-0001,DEA,DEA-2017-0010,Schedules of Controlled Substances: Temporary Placement of FUB-AMB into Schedule I,Proposed Rule,,2017-09-11T04:00:00Z,2017,9,,,2017-09-11T18:59:42Z,2017-17639,0,0,0900006482b23e2a
DEA-2017-0008-0001,DEA,DEA-2017-0008,Schedules of Controlled Substances: Removal of Naldemedine from Control,Proposed Rule,,2017-07-12T04:00:00Z,2017,7,2017-07-12T04:00:00Z,2017-08-12T03:59:59Z,2017-08-11T01:02:14Z,2017-14482,0,0,0900006482910c2c
DEA-2017-0005-0001,DEA,DEA-2017-0005,Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I,Proposed Rule,,2017-06-02T04:00:00Z,2017,6,,,2017-06-02T13:11:59Z,2017-11215,0,0,090000648267f8ac
DEA-2017-0004-0001,DEA,DEA-2017-0004,Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I,Proposed Rule,,2017-03-23T04:00:00Z,2017,3,,,2017-03-23T13:53:51Z,2017-05728,0,0,090000648251fac5